J. Tsui

发表

Clinical observations on the rate of progression of idiopathic parkinsonism.

M Schulzer, D B Calne, B. Snow, 1994, Brain : a journal of neurology.

The long-term response to levodopa in dopa-responsive dystonia.

D. Calne, R. de la Fuente-Fernández, J. Tsui, 2001, Parkinsonism & related disorders.

Treatment of dystonia in Parkinson's disease.

J. Tsui, 2003, Advances in neurology.

Parkinson’s Disease: Clinical Trials

D. Calne, M. Schulzer, J. Tsui, 1986 .

Daytime somnolence in patients with Parkinson's disease.

W. Martin, D. Calne, M. Schulzer, 2001, Parkinsonism & related disorders.

Transdermal dopaminergic D2 receptor agonist therapy in Parkinson's disease with N‐0923 TDS: A double‐blind, placebo‐controlled study

R. Pahwa, A. Samii, W. Koller, 2001 .

Botulinum toxin in spasmodic torticollis.

A. Eisen, D. Calne, J. Tsui, 1988, Advances in neurology.

Cervical dystonia (CD) is characterized by sustained or intermittent contractions of neck muscles, causing twisting and repetitive movements or abnormal posture of the head.1 The frequency of hand, arm, and head tremor in CD patients

A. Samii, M. Schulzer, E. Mak, 2002 .

Expression of glial cell line-derived neurotrophic factor and its mRNA in the nigrostriatal pathway following MPTP treatment

F. Suzuki, J. Tsui, Takuro Inoue, 1999, Brain Research.

Botulinum toxin in the treatment of writer's cramp

D. Calne, S. Calne, J. Tsui, 1993, Neurology.

A Pilot Study on the Use of Botulinum Toxin in Spasmodic Torticollis

J. Carruthers, A. Eisen, D. Calne, 1985, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Occupational Risk Factors in Parkinson’s Disease

D. Calne, M. Schulzer, S. Marion, 1999 .

Attenuation of renal vasopressin V2 receptor upregulation by bosentan, an ETA/ETB receptor antagonist.

N. Wong, J. Tsui, M. Sonntag, 2003, Metabolism: clinical and experimental.

Vasopressin regulates endothelin-B receptor in rat inner medullary collecting duct.

N. Wong, B. P. Wong, J. Tsui, 2000, American journal of physiology. Renal physiology.

Angiotensin regulates endothelin-B receptor in rat inner medullary collecting duct.

N. Wong, J. Tsui, 2001, Metabolism: clinical and experimental.

The Canadian multicentre study of deep brain stimulation for cervical dystonia.

M. Eliasziw, Z. Kiss, O. Suchowersky, 2007, Brain : a journal of neurology.

Botulinum toxin as a therapeutic agent.

J. Tsui, Joseph K.C. Tsui, 1996, Pharmacology & therapeutics.

Clustering of Parkinson disease: shared cause or coincidence?

Z. Wszolek, D. Calne, M. Schulzer, 2004, Archives of neurology.

Optimal Indices for Testing Parkinsonian Rigidity

H Teräväinen, D B Calne, H. Teräväinen, 1989, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

DNAJC13 genetic variants in parkinsonism

Martin J. McKeown, A. Rajput, A. Rajput, 2015, Movement disorders : official journal of the Movement Disorder Society.

Regulation of aquaporin-4 in a traumatic brain injury model in rats.

C. Honey, N. Wong, J. Tsui, 2003, Journal of neurosurgery.

Occupational risk factors in Parkinson's disease.

D. Calne, M. Schulzer, S. Marion, 1999, Canadian journal of public health = Revue canadienne de sante publique.

Lamotrigine trial in idiopathic parkinsonism

R. Uitti, D. Calne, M. Schulzer, 1997, Neurology.

Occupational and environmental risk factors for Parkinson's disease.

K Teschke, S A Marion, K. Teschke, 2002, Parkinsonism & related disorders.

Angiotensin II upregulates the expression of vasopressin V2 mRNA in the inner medullary collecting duct of the rat.

N. Wong, J. Tsui, 2003, Metabolism: clinical and experimental.

Handbook of dystonia

D. Calne, J. Tsui, 1995 .

The effect of dietary protein on the efficacy of L‐dopa

W. Woodward, D. Calne, S. Calne, 1989, Neurology.

Idiopathic cervical dystonia: Report of discordance in a pair of monozygotic twins.

J. Tsui, J. Tsui, J. H. Chan, 1997, Parkinsonism & related disorders.

Head Tremor in Cervical Dystonia

M Schulzer, A. Samii, P. Pal, 2000, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Cerebral glucose metabolism in Parkinson's disease with and without dementia.

M Schulzer, D B Calne, A. Phillips, 1992, Archives of neurology.

Evaluation of Parkinson’s Disease

H. Teräväinen, D. Calne, J. Tsui, 1989 .

Unilateral pallidotomy for reduction of parkinsonian pain.

C. Honey, D. Calne, Joseph, 1999, Journal of neurosurgery.

Association of Parkinson's disease with infections and occupational exposure to possible vectors

K. Teschke, M. A. Harris, S. Marion, 2012, Movement disorders : official journal of the Movement Disorder Society.

A double‐blind, placebo‐controlled, dose‐ranging study to investigate the safety and efficacy of CY 208‐243 in patients with Parkinson's disease

E. Wolters, D. Calne, R. Peppard, 1989, Neurology.

Upregulation of vasopressin V2 and aquaporin 2 in the inner medullary collecting duct of cardiomyopathic hamsters is attenuated by enalapril treatment.

N. Wong, J. Tsui, 2002, Metabolism: clinical and experimental.

Alternating two finger tapping with contralateral activation is an objective measure of clinical severity in Parkinson's disease and correlates with PET

A. Samii, M. Schulzer, A. Stoessl, 2001, Parkinsonism & related disorders.

The prevalence of Parkinson's disease in British Columbia, Canada, estimated by using drug tracer methodology.

K. Teschke, M. Schulzer, S. Marion, 2003, Parkinsonism & related disorders.

Clinical Trials for Parkinson’s Disease

H. Teräväinen, D. Calne, J. Tsui, 1989 .

A scan without evidence is not evidence of absence: Scans without evidence of dopaminergic deficit in a symptomatic leucine‐rich repeat kinase 2 mutation carrier

V. Sossi, Yu-Shin Ding, P. Schaffer, 2016, Movement disorders : official journal of the Movement Disorder Society.

Future treatment of Parkinson's disease.

J. Tsui, 1992, The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques.